End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 NZD | -3.45% | -6.67% | -20.00% |
May. 01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
Apr. 24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
Sales 2024 * | 193M 116M | Sales 2025 * | 220M 133M | Capitalization | 294M 177M |
---|---|---|---|---|---|
Net income 2024 * | 15M 9.03M | Net income 2025 * | 17M 10.23M | EV / Sales 2024 * | 1.67 x |
Net Debt 2024 * | 28.28M 17.02M | Net Debt 2025 * | 26.88M 16.18M | EV / Sales 2025 * | 1.46 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
16.9
x | Employees | 100 |
Yield 2024 * |
0.58% | Yield 2025 * |
0.81% | Free-Float | 25.53% |
Latest transcript on AFT Pharmaceuticals Limited
1 day | -3.45% | ||
1 week | -6.67% | ||
Current month | -6.67% | ||
1 month | -11.11% | ||
3 months | -25.53% | ||
6 months | -15.92% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Marree Atkinson
FOU | Founder | - | 97-09-03 |
Hartley Atkinson
FOU | Founder | - | 97-09-03 |
Malcolm Tubby
DFI | Director of Finance/CFO | - | 97-09-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Theodore Witek
BRD | Director/Board Member | 67 | 20-12-22 |
David Flacks
CHM | Chairman | - | 15-06-21 |
Hartley Atkinson
FOU | Founder | - | 97-09-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.8 | -3.45% | 10,676 |
24-05-09 | 2.9 | -1.02% | 16,372 |
24-05-08 | 2.93 | +1.03% | 103,317 |
24-05-07 | 2.9 | -2.36% | 32,435 |
24-05-06 | 2.97 | -1.00% | 13,505 |
End-of-day quote New Zealand S.E., May 09, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 177M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- AFT Stock